| pubmed-article:6540611 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6540611 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:6540611 | lifeskim:mentions | umls-concept:C0020852 | lld:lifeskim |
| pubmed-article:6540611 | lifeskim:mentions | umls-concept:C0272293 | lld:lifeskim |
| pubmed-article:6540611 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:6540611 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6540611 | pubmed:dateCreated | 1984-10-1 | lld:pubmed |
| pubmed-article:6540611 | pubmed:abstractText | Sixteen adult patients of mean age 48 years with chronic ITP were studied for platelet response to high-dose (0.4 g/kg body weight per day for five consecutive days) intravenous polyvalent intact IgG in the absence of any concurrent treatment. The platelet count returned to normal values in nine patients, a partial response (rise in the platelet count between 50 and 150 X 10(9)/1) was observed in three cases. One patient refractory to any other treatment went into a sustained remission. In the other responsive patients the response was only transient. Among seven splenectomised patients only three responded to IgG infusions versus nine in the non-splenectomised group. The length of ITP history appeared as a more critical factor for the response to IgG than previous splenectomy. | lld:pubmed |
| pubmed-article:6540611 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6540611 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6540611 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6540611 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6540611 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6540611 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6540611 | pubmed:issn | 0006-5242 | lld:pubmed |
| pubmed-article:6540611 | pubmed:author | pubmed-author:LangJ MJM | lld:pubmed |
| pubmed-article:6540611 | pubmed:author | pubmed-author:OberlingFF | lld:pubmed |
| pubmed-article:6540611 | pubmed:author | pubmed-author:BergeratJ PJP | lld:pubmed |
| pubmed-article:6540611 | pubmed:author | pubmed-author:GironCC | lld:pubmed |
| pubmed-article:6540611 | pubmed:author | pubmed-author:FaradjiAA | lld:pubmed |
| pubmed-article:6540611 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6540611 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:6540611 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6540611 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6540611 | pubmed:pagination | 95-9 | lld:pubmed |
| pubmed-article:6540611 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:meshHeading | pubmed-meshheading:6540611-... | lld:pubmed |
| pubmed-article:6540611 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6540611 | pubmed:articleTitle | High-dose intravenous IgG for chronic idiopathic thrombocytopenic purpura in adults. | lld:pubmed |
| pubmed-article:6540611 | pubmed:publicationType | Journal Article | lld:pubmed |
